Cargando…
1260MO Activity of OSE-2101 in HLA-A2+ non-small cell lung cancer (NSCLC) patients after failure to immune checkpoint inhibitors (ICI): Step 1 results of phase III ATALANTE-1 randomised trial
Autores principales: | Giaccone, G., Felip, E., Cobo, M., Campelo, R. Garcia, DENIS, F., Quoix, E., Madroszyk, A., Debieuvre, D., Hilgers, W., Moran, T., Galetta, D., Romano, G.D., Cappuzzo, F., Robinet, G., Masson, P., Viteri, S., Peled, N., Costantini, D., Dziadziuszko, R., Besse, B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506388/ http://dx.doi.org/10.1016/j.annonc.2020.08.1574 |
Ejemplares similares
-
L'Atalante
Publicado: (1996) -
2101. CMV Infections in Multiple Myeloma Patients
por: Ilyas, Sahrish, et al.
Publicado: (2022) -
P1260: UNRAVELING THE GENETICS OF TRANSFORMED SPLENIC MARGINAL ZONE LYMPHOMA
por: Grau, M., et al.
Publicado: (2022) -
α-d-Tagatopyranose
por: Punzo, Francesco, et al.
Publicado: (2009) -
Multichannel Cell Detection in Microcompartments by Means of True Parallel Measurements using the Solartron S-1260
por: Nguyen, T.A., et al.
Publicado: (2020)